Microbot Medical (MBOT) revenue and earnings history
Microbot Medical's annual figures for 18 fiscal years, as filed with the SEC.
Over 6 years, from fiscal 2009 to fiscal 2015, revenue grew at a compound rate of −30.0% a year.
Revenue and net income, 18 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | — | −$14.7M | −$13.1M | −$13M | $60K | −$13.1M | $1.06M | — | — | $3.91M | — | 10-K |
| 2024ended Dec 31, 2024 | — |
The latest quarter, insider trades and fund moves: Microbot Medical (MBOT) on OQRO.
Common questions
How fast has Microbot Medical's revenue grown?
From $993K in fiscal 2009 to $117K in fiscal 2015: a compound annual growth rate of −30.0% over 6 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Microbot Medical been profitable?
It reported a net loss in 18 of the years shown (2009, 2010, 2011, 2012, 2013, 2014, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025). The highest net income was −$921K in fiscal 2015.
What was Microbot Medical's free cash flow in fiscal 2025?
Where these figures come from
The SEC’s companyfacts data: every figure Microbot Medical tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
